DUBLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) — The “CROs (Clinical Research Organizations) – Identification, Selection and Management for Maximum Outcomes and Maximum Value” training added ResearchAndMarkets.com Offer.
This CRO training provides all the specific methodologies and management techniques to successfully outsource pharmaceutical programs, completed on time and within budget, and most importantly, completed with a high level of quality and performance.
This course provides participants with all the specific methodologies and management techniques to successfully outsource pharmaceutical programs that are completed on time, within budget, and most importantly, with a high level of quality and performance.
Participants will gain an in-depth perspective that focuses on the components of performance- and quality-based management of drug development. Attendees will learn how current external and internal forces are shaping the way projects need to be delivered given the state of the industry to be competitive and cost effective.
Particular attention is paid to defining meaningful Key Performance Indicators (KPIs), implementing these indicators into the process and collecting/analyzing data to proactively deliver quality studies.
Pharmaceutical and biotechnology research managers and their peers in the CRO industry will gain a thorough understanding of how implementing outsourcing scorecards allows them to collaborate to achieve successful outsourcing programs.
The processes involved in managing CROs, including study plans, on-site visits, preparation for inspections, oversight of assessment programs, progress and conditions for termination of a CRO’s services are analyzed along with general data quality assurance requirements. Problem assessment and resolution solutions that affect all outsourcing projects, as well as the legal requirements of sponsors and CROs are discussed.
learning goals
Ultimately, the challenge facing…
